Medipal Holdings P/S 2024

Medipal Holdings Aktienanalyse

What does Medipal Holdings do?

Medipal Holdings Corp is a leading Japanese company operating in various areas of the healthcare industry. Founded in 1995, the company has emerged as a key player in the Japanese healthcare sector and beyond. The company operates in different sectors to offer a wide range of products and services. These segments include wholesale and retail distribution of pharmaceuticals and healthcare products, hospital management, pharmaceutical manufacturing and medical technology, as well as pharmaceutical research and development. Medipal Holdings Corp's business model is to provide a complete supply chain in the healthcare industry, ranging from the manufacturing of pharmaceuticals and medical technology to the supply of doctors and hospitals. The company aims to provide a broad range of healthcare products and services that meet the needs of patients and healthcare providers. The pharmaceutical and healthcare products segment has made the company one of the leading distributors in Japan. Medipal Holdings Corp is a key partner for international companies looking to enter the Japanese market. This segment works closely with various medical facilities to ensure the smooth distribution of drugs and products. It also operates a retail chain of pharmacies that focuses on patient consultation. Hospital management is another important segment of Medipal Holdings Corp. The company is a major operator of hospitals in Japan and also operates senior facilities in the country. It is committed to high-quality medical care and improving the patient experience in its facilities. The company has also developed a program for international patients to meet the needs of foreign patients. The manufacturing of pharmaceuticals and medical technology is another important part of Medipal Holdings Corp's business. The company produces generics and also has partnerships with international pharmaceutical companies for the import and distribution of pharmaceutical products. Medipal Holdings Corp also invests in the research and development of new drugs and medical technology. The pharmaceutical research and development segment is one of Medipal Holdings Corp's newest initiatives. The company invests in the research of new drugs and medical technologies to expand its offering of healthcare products and services. It has its own research and development center as well as partnerships with other companies and institutions. In summary, Medipal Holdings Corp is a key player in the Japanese healthcare industry. The company has developed a wide range of healthcare products and services to meet the needs of patients and healthcare providers. It aims to provide a complete supply chain in the healthcare industry, ranging from the manufacturing of pharmaceuticals and medical technology to the supply of doctors and hospitals. Medipal Holdings Corp has a strong position in the pharmaceutical and healthcare products market as well as in hospital management, and is committed to improving the patient experience and researching new healthcare products. Medipal Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Medipal Holdings's P/S Ratio

Medipal Holdings's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Medipal Holdings's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Medipal Holdings's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Medipal Holdings’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Medipal Holdings stock

What is the price-to-earnings ratio of Medipal Holdings?

The price-earnings ratio of Medipal Holdings is currently 0.14.

How has the price-earnings ratio of Medipal Holdings changed compared to last year?

The price-to-earnings ratio of Medipal Holdings has increased by 0% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Medipal Holdings high compared to other companies?

Yes, the price-to-earnings ratio of Medipal Holdings is high compared to other companies.

How does an increase in the price-earnings ratio of Medipal Holdings affect the company?

An increase in the price-earnings ratio of Medipal Holdings would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Medipal Holdings affect the company?

A decrease in the price-earnings ratio of Medipal Holdings would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Medipal Holdings?

Some factors that influence the price-earnings ratio of Medipal Holdings are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Medipal Holdings pay?

Over the past 12 months, Medipal Holdings paid a dividend of 60 JPY . This corresponds to a dividend yield of about 2.37 %. For the coming 12 months, Medipal Holdings is expected to pay a dividend of 62.18 JPY.

What is the dividend yield of Medipal Holdings?

The current dividend yield of Medipal Holdings is 2.37 %.

When does Medipal Holdings pay dividends?

Medipal Holdings pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Medipal Holdings?

Medipal Holdings paid dividends every year for the past 23 years.

What is the dividend of Medipal Holdings?

For the upcoming 12 months, dividends amounting to 62.18 JPY are expected. This corresponds to a dividend yield of 2.45 %.

In which sector is Medipal Holdings located?

Medipal Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipal Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipal Holdings from 12/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Medipal Holdings pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Medipal Holdings in the year 2023?

In the year 2023, Medipal Holdings distributed 53 JPY as dividends.

In which currency does Medipal Holdings pay out the dividend?

The dividends of Medipal Holdings are distributed in JPY.